Taigen Biopharmaceutica (Taiwan) Buy Hold or Sell Recommendation
| 4157 Stock | TWD 11.45 0.35 2.97% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Taigen Biopharmaceuticals Holdings is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Taigen Biopharmaceuticals Holdings given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Taigen Biopharmaceuticals Holdings, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Taigen Biopharmaceutica Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Taigen and provide practical buy, sell, or hold advice based on investors' constraints. Taigen Biopharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Taigen |
Execute Taigen Biopharmaceutica Buy or Sell Advice
The Taigen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Taigen Biopharmaceuticals Holdings. Macroaxis does not own or have any residual interests in Taigen Biopharmaceuticals Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Taigen Biopharmaceutica's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Taigen Biopharmaceutica Trading Alerts and Improvement Suggestions
| Taigen Biopharmaceutica generated a negative expected return over the last 90 days | |
| Taigen Biopharmaceutica has high likelihood to experience some financial distress in the next 2 years | |
| About 36.0% of the company shares are owned by insiders or employees |
Taigen Biopharmaceutica Returns Distribution Density
The distribution of Taigen Biopharmaceutica's historical returns is an attempt to chart the uncertainty of Taigen Biopharmaceutica's future price movements. The chart of the probability distribution of Taigen Biopharmaceutica daily returns describes the distribution of returns around its average expected value. We use Taigen Biopharmaceuticals Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Taigen Biopharmaceutica returns is essential to provide solid investment advice for Taigen Biopharmaceutica.
| Mean Return | -0.31 | Value At Risk | -2.39 | Potential Upside | 2.08 | Standard Deviation | 1.52 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Taigen Biopharmaceutica historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Taigen Biopharmaceutica Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Taigen Biopharmaceutica or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Taigen Biopharmaceutica's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Taigen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.3 | |
β | Beta against Dow Jones | -0.25 | |
σ | Overall volatility | 1.53 | |
Ir | Information ratio | -0.27 |
Taigen Biopharmaceutica Volatility Alert
Taigen Biopharmaceuticals Holdings exhibits very low volatility with skewness of -0.8 and kurtosis of 4.88. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Taigen Biopharmaceutica's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Taigen Biopharmaceutica's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Taigen Biopharmaceutica Fundamentals Vs Peers
Comparing Taigen Biopharmaceutica's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Taigen Biopharmaceutica's direct or indirect competition across all of the common fundamentals between Taigen Biopharmaceutica and the related equities. This way, we can detect undervalued stocks with similar characteristics as Taigen Biopharmaceutica or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Taigen Biopharmaceutica's fundamental indicators could also be used in its relative valuation, which is a method of valuing Taigen Biopharmaceutica by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Taigen Biopharmaceutica to competition |
| Fundamentals | Taigen Biopharmaceutica | Peer Average |
| Return On Equity | -0.21 | -0.31 |
| Return On Asset | -0.15 | -0.14 |
| Operating Margin | (9.40) % | (5.51) % |
| Current Valuation | 11.41 B | 16.62 B |
| Shares Outstanding | 716.84 M | 571.82 M |
| Shares Owned By Insiders | 35.93 % | 10.09 % |
| Shares Owned By Institutions | 24.94 % | 39.21 % |
| Price To Book | 11.51 X | 9.51 X |
| Price To Sales | 369.99 X | 11.42 X |
| Revenue | 1.29 B | 9.43 B |
| Gross Profit | 1.28 B | 27.38 B |
| EBITDA | 905.1 M | 3.9 B |
| Net Income | 775.62 M | 570.98 M |
| Book Value Per Share | 1.50 X | 1.93 K |
| Cash Flow From Operations | 629.07 M | 971.22 M |
| Earnings Per Share | 1.08 X | 3.12 X |
| Number Of Employees | 23 | 18.84 K |
| Beta | 0.93 | -0.15 |
| Market Capitalization | 11.33 B | 19.03 B |
| Total Asset | 1.39 B | 29.47 B |
| Net Asset | 1.39 B |
Taigen Biopharmaceutica Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Taigen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Taigen Biopharmaceutica Buy or Sell Advice
When is the right time to buy or sell Taigen Biopharmaceuticals Holdings? Buying financial instruments such as Taigen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Taigen Biopharmaceutica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Dividend Beast Thematic Idea Now
Dividend Beast
An experimental equal-weighted theme of equities with high dividend yield and solid fundamentals based on Macroaxis rating system. The Dividend Beast theme has 69 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Dividend Beast Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Taigen Stock Analysis
When running Taigen Biopharmaceutica's price analysis, check to measure Taigen Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taigen Biopharmaceutica is operating at the current time. Most of Taigen Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Taigen Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taigen Biopharmaceutica's price. Additionally, you may evaluate how the addition of Taigen Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.